drugset / Trial / NCT04712357
Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19
Unknown
219 enrolled
Federal University of Ceará
Central Laboratory of Public Health of Ceará - Lacen-CE · collabConselho Nacional de Desenvolvimento Científico e Tecnológico · collabSão José Hospital for Infectious Diseases - HSJ · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Clinical, control, double-blind, randomized trial with tenofovir disoproxyl fumarate and emtricitabine for Covid-19
Timeline
- Start
- 2020-11-09
- Primary completion
- 2022-01
- Completion
- 2023-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tenofovir disoproxyl fumarate | Unknown | 300 mg | Oral |
| Comparator | emtricitabine | Other / unclassified | 200 mg | Oral |